An EYA3/NF-κB/CCL2 signaling axis suppresses cytotoxic NK cells in the pre-metastatic niche to promote triple negative breast cancer metastasis.
Sheera R RosenbaumConnor J HughesKaiah M FieldsStephen Connor PurdyAnnika GustafsonArthur WolinDrake HamptonNicholas TurnerChristopher EbmeierJames C CostelloHeide L FordPublished in: bioRxiv : the preprint server for biology (2024)
EYA3 promotes metastasis of TNBC cells by promoting NF-kB-mediated CCL2 expression and inhibiting cytotoxic NK cells at the pre-metastatic niche, highlighting a potential therapeutic target in this subset of breast cancer.